The Bottom Line
The Part D Premium Stabilization Demonstration is ending after 2026. That removes a temporary cushion that reduced participating stand-alone plan premiums by as much as $10 per month in 2026 and limited year-over-year premium growth. It does not mean every enrollee will face the same increase—or any increase. Plan-level premiums, formularies and pharmacy networks for 2027 still need to be reviewed when they are released.
What changed
The demonstration was introduced in 2025 as Medicare Part D moved into a redesigned benefit with a new annual out-of-pocket limit. It provided extra federal payments to participating stand-alone prescription drug plans, or PDPs, to reduce the premium charged to beneficiaries and limit how quickly it could rise.
According to the Medicare Payment Advisory Commission, the program reduced participating premiums by up to $15 a month in 2025 and capped the annual increase at $35. For 2026, the premium reduction fell to as much as $10 and the increase limit widened to $50. The program was always temporary, and its scheduled end means those protections will no longer shape 2027 PDP bids in the same way.
The immediate news is about the removal of a subsidy mechanism—not a final price list for consumers. CMS has said 2027 premium information will become available in September. Until plan-specific notices and Medicare Plan Finder data are published, claims about a universal dollar increase are estimates rather than confirmed household costs.
The 2026 baseline
| Measure | 2026 figure | Why it matters |
|---|---|---|
| Average stand-alone PDP premium | $36/month | An enrollment-weighted average; an individual plan may be much higher or lower. |
| Average MA-PD drug premium | $8/month | Medicare Advantage drug coverage follows different pricing dynamics. |
| Standard Part D deductible | $615 | Premium is only one part of total annual drug cost. |
| Open Enrollment | Oct. 15–Dec. 7 | Changes selected in this window generally start Jan. 1. |
Premium figures are KFF estimates based on 2026 enrollment; the deductible and enrollment dates are from Medicare. These figures describe 2026 and should not be read as 2027 projections.
Three things the announcement does not mean
1. It does not guarantee that every premium will rise
Plans compete locally and price their coverage based on bids, enrollment, formularies and other factors. Some premiums may increase, some may remain close to current levels, and some could decline. A CMS official told the Associated Press that most beneficiaries were expected to see increases of less than $10 a month and that some could pay less. That is an administration estimate, not a guarantee for any specific plan.
2. It does not end Medicare drug coverage
Part D remains in place. The change concerns a temporary premium-stabilization program for stand-alone plans. Beneficiaries will still be able to compare and enroll in stand-alone PDPs or Medicare Advantage plans with drug coverage, subject to the choices available in their area.
3. The premium alone does not show the cheapest plan
A low monthly premium can be outweighed by a deductible, higher copays, coinsurance, a nonpreferred pharmacy or a drug moving to a more expensive tier. The useful comparison is estimated total annual cost for the prescriptions and pharmacies a household actually uses.
Your fall comparison checklist
- Open the Annual Notice of Change. Check premium, deductible, copays and coinsurance.
- Re-enter every prescription. Confirm the drug is covered, its tier and any prior-authorization or step-therapy rules.
- Check the pharmacy network. Compare preferred retail, standard retail and mail-order costs.
- Compare total annual cost. Include 12 months of premiums plus expected out-of-pocket drug spending.
- Review assistance. People with limited income and resources should check eligibility for Medicare’s Extra Help program.
- Save the evidence. Keep the plan’s notice, formulary and the date of the comparison.
A practical scenario map
If the premium rises but your medicines remain on favorable tiers: calculate the full annual increase before switching. A different plan with a lower premium may charge more for the prescriptions you use.
If a medicine changes tier or leaves the formulary: the coverage change may matter more than the premium. Ask the plan and your prescriber about covered alternatives, exceptions and transition rules.
If your preferred pharmacy becomes nonpreferred: price the same medicine at another in-network pharmacy. The savings can exceed a modest monthly premium difference.
If you receive Extra Help: do not assume the standard premium figures describe your net cost. Compare plans using your subsidy status and watch for plan reassignment notices.
What to Watch
- September: CMS and plans are expected to release 2027 premium and benefit details.
- Before Oct. 15: review the Annual Notice of Change and update your medication list.
- Oct. 15–Dec. 7: compare total annual costs in Medicare Plan Finder and make any change.
- Jan. 1, 2027: confirm the new premium, pharmacy status and first refill cost.
Sources and Methodology
This analysis separates confirmed 2026 program rules and current enrollment data from statements about 2027. The 2027 impact remains plan-specific until final premiums, formularies and networks are released.
- Associated Press: Medicare drug-plan subsidy program ending
- MedPAC: Report to Congress, March 2026, Chapter 13
- KFF: Medicare Part D enrollment, premiums and cost sharing in 2026
- CMS: 2026 Part D bid information and demonstration parameters
- Medicare: Open Enrollment
- Medicare: Part D costs
Read Also
Latest News | Podcasts
Information notice: This article is for general educational purposes and is not individualized insurance, medical or financial advice. Plan availability and costs vary by location and personal circumstances. Confirm details with Medicare and the plan before making a coverage decision.
